Skip to main content
. 2019 Jul 19;14(7):e0219922. doi: 10.1371/journal.pone.0219922

Table 1. Baseline characteristics of study population.

Variables HIV-Positive
n = 148 (59.7%)
HIV-Negative
n = 100 (40.3%)
P-value
Age (years) 29.1 ± 6.1 28.9 ± 6.4 0.804*
15–19 14 (46.7) 16 (53.3) 0.299†
20–30 82 (61.2) 52 (38.8)
>30Years 52 (61.9) 32 (38.1)
History of sharing razors blades and pins <0.0001
Ever 60 (78.9) 16 (21.1)
Never 88 (51.1) 84 (48.9)
History of blood transfusion 0.408‡
Ever 28 (77.8) 8 (22.2)
Never 120 (56.6) 92 (43.4)
Period of HIV diagnosis N/A
Before pregnancy 34 (23.0) -
During pregnancy 114 (77.0) -
If during pregnancy, at what stage? N/A
First trimester 14 (12.3) -
Second trimester 60 (52.6) -
Third trimester 40 (35.1) -
Medication used
3TC+AZT+EFV 4 (2.7) - N/A
3TC+TDF+EFV 12 (8.1) - N/A
3TC+AZT+NVP 132 (89.2) - N/A
Marital status 0.039‡
Single 44 (71.0) 18 (29.0)
Married 104 (55.9) 82 (44.1)
Employment status 0.007
Formal 14 (50.0) 14 (50.0)
Informal 100 (56.2) 78 (43.8)
Unemployed 34 (81.0) 8 (19.0)
BMI (kg/m2) 26.90 ± 3.91 23.17 ± 3.55 <0.0001*
Underweight 16 (72.7) 6 (27.3) <0.0001
Normal 64 (45.7) 76 (54.3)
Overweight 68 (79.1) 18 (20.9)
Haematology
Haemoglobin (g/dl) 9.7 ± 1.81 10.75 ± 1.68 <0.0001*
WBC (103/μL) 5.60 ± 1.81 7.23 ± 2.13 <0.0001*
Platelet count (103/μL) 220.62 ± 86.73 209.38 ± 65.59 0.272*

Continuous data is presented as Mean ± SD. Categorical data is presented as frequency (%).

Chi square† and Fisher‡ exact test was performed to compare categorical variables.

*Independent t-test was performed to compare continuous variables.

Lamivudine (3TC), Zidovudine (AZT), Nevirapine (NVP), Tenofovir (TDF), Efavirenz (EFV). N/A: Not applicable, p < 0.05 was considered statistically significant (p values of significant variables are in bold print).